May 21, 2021 /

Webinar: ASP0367 Development Program Update (May 19, 2021)

by: Parent Project Muscular Dystrophy

Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program.

Research & Clinical Trial Webinars,

4 years ago

You may also like

World Muscle Society 2024: CIFFREO Data Discussion with Pfizer

World Muscle Society 2024: CIFFREO Data Discussion with Pfizer

9 months ago

Research & Clinical Trial Webinars,

fordadistrogene movaparvovec,

Webinar: SHIELD DMD - A Bone Health Study in Duchenne

Webinar: SHIELD DMD – A Bone Health Study in Duchenne

10 months ago

Research & Clinical Trial Webinars,

Webinar: Interim Results from FORWARD-53 Study of WVE-N531 in Duchenne Muscular Dystrophy

Webinar: Interim Results from FORWARD-53 Study of WVE-N531 in Duchenne Muscular Dystrophy

10 months ago

Research & Clinical Trial Webinars,

wave life sciences,

Webinar: Overview of DUVYZAT and Access Resources (September 2024)

Webinar: Overview of DUVYZAT and Access Resources (September 2024)

10 months ago

Research & Clinical Trial Webinars,

Webinar: Advocating for A Successful School Year (September 2024)

Webinar: Advocating for A Successful School Year (September 2024)

11 months ago

Webinar: PPMD Advocacy - Raising Our Voices in 2024 and Beyond [Sep 2024]

Webinar: PPMD Advocacy – Raising Our Voices in 2024 and Beyond [Sep 2024]

11 months ago

Webinar: Advancing DYNE-251 - An Investigational Medicine for Duchenne to Deliver for Patients

Webinar: Advancing DYNE-251 – An Investigational Medicine for Duchenne to Deliver for Patients

11 months ago

Research & Clinical Trial Webinars,

dyne therapeutics,

Webinar: Edgewise Therapeutics - Clinical Trials in Becker Muscular Dystrophy

Webinar: Edgewise Therapeutics – Clinical Trials in Becker Muscular Dystrophy

12 months ago

Research & Clinical Trial Webinars,

«1 234 5…27 »

Page 3 of 27

Join Our Mailing List